Best-case series for the use of immuno-augmentation therapy and naltrexone for the treatment of cancer
Contributors: United States. Agency for Healthcare Research and Quality.
Series: Evidence report/technology assessment -- no. 78.; AHRQ pub -- no. 03-E029.; AHRQ publication -- no. 03-E 029.
Publisher: Agency for Healthcare Research and Quality
Published: 2003
Place of publication: [Rockville, Md.]
Language: eng
Format: Electronic resource
Subjects: Cancer -- Treatment.; Naltrexone.
Other titles: Best case series for the use of immuno-augmentation therapy and naltrexone for the treatment of cancer.
Notes: Title from title screen (viewed on Apr. 27, 2004).

Mode of access: Internet from the AHRQ web site. Address as of 4/27/04: http://www.ahrq.gov/clinic/epcsums/immaugsum.pdf; current access available via PURL.